Established in 2015, the Center for Vaccines and Immunology (CVI) provides an environment for world-class research and training in immunology. The CVI is advancing fundamental and translational immunological knowledge to develop new vaccines and therapies for infectious diseases and other immunity-related diseases and syndromes.
Infographic with Center for Vaccines & Immunology (CVI) surrounded by 5 main goals of center activity
UGA’s collaborative research explores the mystery of Influenza B, tracking the Victoria and Yamagata lineages to improve vaccine design and predict the virus’s future evolutionary path.
Influenza hemagglutinin and neuraminidase multivalent vaccine elicits broader protective immune responses compared to vaccine formulations composed of hemagglutinin and neuraminidase
Hum Vaccin Immunother. December 2025
Elicitation of neutralizing antibodies and IgG4 subclass switching following booster vaccination with ancestral COVID-19 mRNA vaccines does not reduce breakthrough infections
Hum Vaccin Immunother. December 2025
Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study
Vaccine. December 2025
N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages
J Virol. November 2025
Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model
Vaccine. October 2025
Active and Passive Immunization of Pan-Fungal Vaccine NXT-2 Reduces Morbidity and Mortality in an Immunosuppressed Murine Model of Candida auris Systemic Infection
Vaccines (Basel). October 2025
